Discuss This Disease

4 free views remaining today

nemaline myopathy

ICD-10 Codes

Related ICD-10:

Description

Nemaline Myopathy: A Disorder Affecting Skeletal Muscles

Nemaline myopathy, also known as rod myopathy or nemaline rod myopathy, is a congenital neuromuscular disorder that primarily affects skeletal muscles. This condition is characterized by muscle weakness (myopathy) throughout the body, with symptoms typically being most severe in the muscles of the face, neck, and limbs.

Key Features:

  • Muscle weakness and poor tone (hypotonia) in the muscles of the face, neck, and upper limbs
  • Affected individuals may experience feeding and swallowing difficulties
  • Respiratory muscles may be affected, leading to breathing problems
  • Severity of symptoms can vary and change throughout life

Types of Nemaline Myopathy:

There are several types of nemaline myopathy, including:

  • Typical congenital nemaline myopathy (most common type)
  • Intermediate congenital nemaline myopathy (fewer symptoms than the severe congenital type)
  • Infantile-onset cases (most severe form)

Symptoms and Effects:

Nemaline myopathy can cause a range of symptoms, including:

  • Muscle weakness and poor tone
  • Breathing problems
  • Feeding and swallowing difficulties
  • Impaired speech ability

The severity of these symptoms can vary and change throughout life.

References:

  • [1] Nemaline myopathy is a disorder that primarily affects skeletal muscles, which are muscles that the body uses for movement. People with nemaline myopathy have muscle weakness (myopathy) throughout the body, but it is typically most severe in the muscles of the face; neck; trunk; and other muscles close to the center of the body [2].
  • [3] Nemaline myopathy causes weakness and poor tone (hypotonia) in the muscles of the face, neck and upper limbs, and often affects the respiratory muscles (those that control breathing). The infantile-onset cases tend to be the most severe. Usually, infants with the disease lack the muscle strength and tone required for simple postures and movements [4].
  • [5] Nemaline myopathy is a congenital, often hereditary neuromuscular disorder with many symptoms that can occur such as muscle weakness, hypoventilation, swallowing dysfunction, and impaired speech ability. The severity of these symptoms varies and can change throughout one's life to some extent [6].

Signs and Symptoms

Nemaline Myopathy Signs and Symptoms

Nemaline myopathy, a congenital neuromuscular disorder, presents with various signs and symptoms that can vary greatly in severity and age of onset. Here are the common manifestations:

  • Muscle Weakness: Muscle weakness is a hallmark symptom of nemaline myopathy, affecting the muscles of the face, neck, upper limbs, and respiratory muscles.
  • Hypotonia: Hypotonia, or low muscle tone, is often present in individuals with nemaline myopathy.
  • Respiratory Difficulties: Weakening of the respiratory muscles can lead to breathing difficulties, increasing the risk of lung infections.
  • Feeding and Swallowing Issues: Infants with nemaline myopathy may experience feeding and swallowing difficulties due to muscle weakness in the face and neck.
  • Skeletal Abnormalities: Skeletal complications such as scoliosis (abnormal curvature of the spine) and joint deformities (contractures) can occur.
  • Foot Deformities: Foot deformities are a common feature of nemaline myopathy, particularly in infants.

Types of Nemaline Myopathy

The severity and age of onset of symptoms vary depending on the type of nemaline myopathy:

  • Typical Congenital Nemaline Myopathy: This is the most common type, accounting for about half of all cases.
  • Intermediate Congenital Nemaline Myopathy: This type causes fewer symptoms than the severe congenital type and more symptoms than the typical congenital type.
  • Infantile-Onset Cases: These tend to be the most severe, with infants lacking muscle strength and experiencing breathing difficulties.

References

  • [1] Signs & Symptoms. The age of onset and severity of symptoms and signs associated with nemaline myopathy vary greatly from person to person.
  • [2] Typical congenital nemaline myopathy: This is the most common type of nemaline myopathy.
  • [3] Nemaline myopathy causes weakness and poor tone (hypotonia) in the muscles of the face, neck and upper limbs, and often affects the respiratory muscles (those that control breathing).
  • [4] People with Nemaline myopathy have muscle weakness (myopathy) throughout the body, but it is typically most severe in the muscles of the face, neck, and limbs.
  • [5] Nemaline myopathy (also called rod myopathy or nemaline rod myopathy) is a congenital, often hereditary neuromuscular disorder.

Additional Symptoms

  • Hypotonia
  • Foot Deformities
  • Skeletal Abnormalities
  • Feeding and Swallowing Issues
  • Respiratory Difficulties
  • muscle weakness

Diagnostic Tests

Diagnostic Tests for Nemaline Myopathy

Nemaline myopathy, a rare genetic disorder affecting skeletal muscles, can be diagnosed through various tests. Here are the diagnostic tests used to confirm the condition:

  • Muscle Biopsy: A muscle biopsy is a surgical procedure where a small sample of muscle tissue is removed and examined for nemaline bodies (thread- or rod-like structures) [1]. This test is often performed when a diagnosis of nemaline myopathy is suspected.
  • Genetic Testing: Genetic testing can confirm the presence of genetic variants associated with nemaline myopathy. This includes sequence analysis, deletion/duplication analysis, targeted variant analysis, and mutation scanning [3][4].
  • Molecular Genetics Tests: These tests analyze specific genes, such as the NEB gene, to detect pathogenic variants responsible for nemaline myopathy [5][7]. A 13-gene panel is also available for patients with a clinical suspicion of nemaline myopathy [6].

Additional Diagnostic Considerations

  • Clinical Evaluation: A thorough clinical evaluation, including a detailed patient and family history, identification of characteristic findings, and molecular testing, can help confirm the diagnosis [2].
  • Multidisciplinary Approach: The diagnosis of nemaline myopathies relies on a multidisciplinary approach with careful clinical, pathological, and genetic correlations [13].

References

[1] Context 1: A biopsy will show thread- or rod-like shapes (nemaline bodies) in the muscle tissue.

[2] Context 2: A diagnosis of nemaline myopathy is suspected based upon a thorough clinical evaluation...

[3] Context 4: Molecular Genetics Tests · Sequence analysis of select exons ...

[4] Context 4: Molecular Genetics Tests · Deletion/duplication analysis ...

[5] Context 5: Genetic testing can assist in diagnosis and identify the specific pathogenic variant responsible...

[6] Context 6: A 13-gene panel that includes assessment of non-coding variants.

[7] Context 7: Nemaline Myopathy - The nemaline myopathy test offers molecular detection of one pathogenic variant in the NEB gene...

[13] Context 13: The diagnosis of nemaline myopathies relies on a multidisciplinary approach...

Treatment

Current Status of Drug Treatment for Nemaline Myopathy

Nemaline myopathy, a rare genetic disorder affecting muscle strength and function, has no curative treatment available. However, various research studies have explored potential drug treatments to alleviate symptoms.

  • Chemotherapy-based approach: A preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein is the chemotherapy-based approach [5][8].
  • Tirasemtiv: Research has been conducted on tirasemtiv, a fast troponin activator, to test its ability to improve muscle strength in nemaline myopathy patients [4].
  • Omecamtiv mecarbil: A study showed that omecamtiv mecarbil, a MYH7 activator, improved force production of type I fibers and demonstrated therapeutic potential for treating nemaline myopathy [7].
  • Pyridostigmine: This drug has been mentioned as a potential treatment option, although its effectiveness is not well established [6].
  • Myostatin inhibitors: Research on small molecule drugs targeting specific molecules or pathways involved in the development of nemaline myopathy holds promise for restoring normal muscle function and improving symptoms [15].

Gene Therapy and Drug Repurposing

Recent research breakthroughs have focused on gene therapy and drug repurposing for nemaline myopathy. A study successfully developed mouse and zebrafish models to understand the disease process and test potential therapies, including gene therapy and drug repurposing [3].

Differential Diagnosis

Differential Diagnosis of Nemaline Myopathy

Nemaline myopathy (NM) is a congenital muscle disorder characterized by the presence of rod-like structures in muscle cells, known as nemaline rods. The differential diagnosis for NM involves excluding other conditions that may present with similar clinical features.

Conditions to Consider:

  • Congenital Muscular Dystrophy: This condition also presents with muscle weakness and hypotonia, but it is typically associated with progressive muscle degeneration.
  • Myotonic Dystrophy Type 1: This genetic disorder can cause muscle stiffness, wasting, and weakness, as well as other systemic features such as cataracts and heart conduction defects.
  • Congenital Myasthenia Gravis: This rare condition is characterized by muscle weakness that worsens with activity and improves with rest.
  • Sporadic Inclusion Body Myositis (sIBM): This autoimmune disorder causes progressive muscle weakness, particularly in the distal muscles of the limbs.

Other Conditions to Consider:

  • Prader-Willi Syndrome: A genetic disorder characterized by muscle hypotonia, feeding difficulties, and other systemic features.
  • Congenital Myopathies: A group of rare disorders that affect muscle development and function.
  • Severe Spinal Muscular Atrophy (SMA): A genetic disorder causing progressive muscle weakness and wasting.

Key Features to Consider in Differential Diagnosis:

  • Muscle weakness and hypotonia
  • Absent or low deep tendon reflexes (hyporeflexia)
  • High-arched palate
  • Bulbar weakness leading to insufficient sucking and swallowing

Genetic Mutations Associated with NM:

  • NEB mutations
  • ACTA1 mutations
  • TPM2, TPM3, KBTBD13, CFL2, KLHL40, and KLHL41 mutations

It is essential to consider these conditions in the differential diagnosis of nemaline myopathy, as they may present with similar clinical features. A thorough diagnostic evaluation, including muscle biopsy and genetic testing, can help confirm the diagnosis of NM.

References:

  • [1] Nemaline myopathy (NM) is one of the most common of the congenital myopathies, ranging in severity from severe forms, which may cause death in infancy to a milder form that presents with hypotonia and muscle weakness.
  • [2] Mutations in 12 genes have been associated with NM, including NEB, ACTA1, TPM2, TPM3, KBTBD13, CFL2, KLHL40, and KLHL41.
  • [10] Typical congenital nemaline myopathy: This is the most common type of nemaline myopathy. It accounts for about half of all cases of NM.
  • [14] Nemaline myopathy (NM) is characterized by congenital onset bulbar and extremity weakness and hypotonia.

Note: The references provided are based on the context information retrieved from a search engine and may not be up-to-date or accurate.

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
Xref MGI.
oboInOwl#id
DOID:3191
core#notation
DOID:3191
oboInOwl#hasDbXref
UMLS_CUI:C0206157
IAO_0000115
A congenital myopathy characterized by generally non-progressive muscle weakness of varying severity and problems with the tone and contraction of skeletal muscles. The muscle cells contain abnormal clumps of threadlike material called nemaline bodies.
oboInOwl#hasExactSynonym
rod myopathy
rdf-schema#label
nemaline myopathy
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0110936
RO_0002452
http://purl.obolibrary.org/obo/SYMP_0000094
relatedICD
http://example.org/icd10/G71.21
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6263
owl#annotatedSource
t422813

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.